Qnexa phentermine/topiramate: Phase II data

In the double-blind, placebo-controlled, U.S. Phase II OB-202 trial in 206 obese patients with Type II diabetes, Qnexa met the primary endpoint of a significant reduction in HbA1c levels vs. placebo. ...